Comparative statistics by cancer site (ICD-10)

Acknowledgements

Statistical methods for cancer survival analysis

Loss-adjusted hospital and population-based survival of cancer patients

Cancer survival in Africa, Asia, Caribbean and Central America: database and attributes

Comparative statistics by registry

Comparative statistics by cancer site (ICD-10)

Registry chapters

An overview of cancer survival in Africa, Asia, Caribbean and Central America: the case for investments in cancer health services

SURVCAN

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

Click on country-registry for comparison

Flag	Country-registry	Registration period	Total registred	%		No. of excluded cases					Included cases
Flag	Country-registry	Registration period	Total registred	HV	DCO	DCO	No. follow-up	Others	Total	%	No.	%
	China - Hong Kong SAR	1996–2001	47	85.1	2.1	1	0	4	5	10.6	42	89.4
	China - Shangai	1992–1995	43	88.4	2.3	1	0	0	1	2.3	42	97.7
	China - Tianjin	1991–1999	53	86.8	0.0	0	0	0	0	0.0	53	100.0
	India - Chennai	1990–1999	92	76.1	0.0	0	6	0	6	6.5	86	93.5
	India - Mumbai	1992–1994	168	86.3	3.0	5	2	0	7	4.2	161	95.8
	Republic of Korea - Seoul	1993–1997	26	88.5	0.0	0	0	0	0	0.0	26	100.0
	Thailand - Khon Kaen	1993–1997	88	85.2	1.1	1	8	0	9	10.2	79	89.8
	Thailand - Lampang	1990–2000	33	97.0	0.0	0	0	0	0	0.0	33	100.0
	Thailand - Songkhla	1990–1999	38	92.1	0.0	0	7	0	7	18.4	31	81.6

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2012 - All Rights Reserved. - Email: www@iarc.fr